Bristol-Myers Squibb and Medical Engineering Corp.
This article was originally published in The Gray Sheet
Executive Summary
Named as defendants in a suit seeking class action status which alleges that the companies' silicone inflatable penile implants are "defective, prone to malfunction, and are unsafe for use in the human body," according to lawyers for the plaintiff. The suit, filed July 5 in federal court in Philadelphia, seeks damages and medical monitoring for patients who received the implants. In May, a similar case was filed in San Francisco against American Medical Systems and Pfizer regarding AMS silicone penile implants ("The Gray Sheet" May 23, p. 32)
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.